Shroom expression is attenuated in pulmonary arterial hypertension

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 871-880

  Sevilla Perez J ^a   Konigshoff M ^a   Kwapiszewska, G ^a   Amarie, O V ^a   Seeger, W ^a   Weissmann, N ^a   Schermuly, R T ^a   Morty, R E ^a   Eickelberg, O ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Actin binding proteins; Animal model; Hypoxia; Pulmonary arterial smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; PDZ PROTEIN; PROTEIN SHROOM; RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL HYPERPLASIA; CELL HYPOXIA; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LASER MICRODISSECTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ACTINS; ANIMALS; ANOXIA; CYTOSKELETON; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY; LUNG; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH; PULMONARY ARTERY;

EID: 58849160460     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00045507     Document Type: Article

References (33)

1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998; 352: 719-725.
2. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.
3. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003; 361: 1533-1544.
4. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 13S-24S.
5. Eickelberg O, Yeager ME, Grimminger F. The tantalizing triplet of pulmonary hypertension-BMP receptors, serotonin receptors, and angiopoietins. Cardiovasc Res 2003; 60: 465-467.
6. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006; 99: 675-691.
7. Solway J, Forsythe SM, Halayko AJ, Vieira JE, Hershenson MB, Camoretti-Mercado B. Transcriptional regulation of smooth muscle contractile apparatus expression. Am J Respir Crit Care Med 1998; 158: S100-S108.
8. Day RM, Agyeman AS, Segel MJ, et al. Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol 2006; 71: 386-397.
9. Schmidt A, Hall MN. Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol 1998; 14: 305-338.
10. Palmgren S, Vartiainen M, Lappalainen P. Twinfilin, a molecular mailman for actin monomers. J Cell Sci 2002; 115: 881-886.
11. Pollard TD, Blanchoin L, Mullins RD. Molecular mechanisms controlling actin filament dynamics in nonmuscle cells. Annu Rev Biophys Biomol Struct 2000; 29: 545-576.
12. Hildebrand JD, Soriano P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 1999; 99: 485-497.
13. Dietz ML, Bernaciak TM, Vendetti F, Kielec JM, Hildebrand JD. Differential actin-dependent localization modulates the evolutionarily conserved activity of Shroom family proteins. J Biol Chem 2006; 281: 20542-20554.
14. Morty RE, Nejman B, Kwapiszewska G, et al. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2007; 27: 1072-1078.
15. Zakrzewicz A, Kouri FM, Nejman B, et al. The TGF-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension. Eur Respir J 2007; 29: 1094-1104.
16. Dumitrascu R, Weissmann N, Ghofrani HA, et al. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006; 113: 286-295.
17. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329-1333.
18. Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, et al. Hyperoxia modulates TGF-β/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292: L537-L549.
19. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 2006; 91: 803-806.
20. Kwapiszewska G, Wilhelm J, Wolff S, et al. Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir Res 2005; 6: 109.
21. Hagens O, Ballabio A, Kalscheuer V, et al. A new standard nomenclature for proteins related to Apx and Shroom. BMC Cell Biol 2006; 7: 18.
22. National Center for Biotechnology Information. Human Genomes Resources. www.ncbi.nlm.nih.gov/projects/genome/guide/human Date last accessed and updated: April 13, 2007.
23. Yoder M, Hildebrand JD. Shroom4 (Kiaa1202) is an actin-associated protein implicated in cytoskeletal organization. Cell Motil Cytoskeleton 2007; 64: 49-63.
24. Hagens O, Dubos A, Abidi F, et al. Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. Hum Genet 2006; 118: 578-590.
25. Weissmann N, Akkayagil E, Quanz K, et al. Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol 2004; 139: 191-202.
26. Stenmark KR, Frid M, Nemenoff R, Dempsey EC, Das M. Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension. Adv Exp Med Biol 1999; 474: 231-258.
27. Erler JT, Cawthorne CJ, Williams KJ, et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol 2004; 24: 2875-2889.
28. Narravula S, Colgan SP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor α expression during hypoxia. J Immunol 2001; 166: 7543-7548.
29. Perros F, Dorfmüller P, Souza R, et al. Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 2007; 29: 937-943.
30. Bentley JK, Hershenson MB. Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc 2008; 5: 89-96.
31. Machado RD, Aldred MA, James V, et al. Mutations of the TGF-β type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 2006; 27: 121-132.
32. Morrell NW. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc Am Thorac Soc 2006; 3: 680-686.
33. Sullivan CC, Du L, Chu D, et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci USA 2003; 100: 12331-12336.